The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ali J. Marian

Department of Medicine

Baylor College of Medicine

Houston

USA

[email]@bcm.tmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Baylor College of Medicine, Houston, USA. 1997 - 2006
  • Baylor College of Medicine, One Baylor Plaza, 519D, Houston, TX 77030, USA. 2004 - 2005
  • Section of Cardiology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza 519D, USA. 2003

References

  1. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. Marian, A.J., Senthil, V., Chen, S.N., Lombardi, R. J. Am. Coll. Cardiol. (2006) [Pubmed]
  2. Recent advances in genetics and treatment of hypertrophic cardiomyopathy. Marian, A. Future. Cardiol (2005) [Pubmed]
  3. Biomarkers of cardiac disease. Marian, A.J., Nambi, V. Expert Rev. Mol. Diagn. (2004) [Pubmed]
  4. On predictors of sudden cardiac death in hypertrophic cardiomyopathy. Marian, A.J. J. Am. Coll. Cardiol. (2003) [Pubmed]
  5. Modifier genes for hypertrophic cardiomyopathy. Marian, A.J. Curr. Opin. Cardiol. (2002) [Pubmed]
  6. The molecular genetic basis for hypertrophic cardiomyopathy. Marian, A.J., Roberts, R. J. Mol. Cell. Cardiol. (2001) [Pubmed]
  7. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Marian, A.J., Salek, L., Lutucuta, S. Minerva Med. (2001) [Pubmed]
  8. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Marian, A.J. Lancet (2000) [Pubmed]
  9. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. Marian, A.J., Safavi, F., Ferlic, L., Dunn, J.K., Gotto, A.M., Ballantyne, C.M. J. Am. Coll. Cardiol. (2000) [Pubmed]
  10. A transgenic rabbit model for human hypertrophic cardiomyopathy. Marian, A.J., Wu, Y., Lim, D.S., McCluggage, M., Youker, K., Yu, Q.T., Brugada, R., DeMayo, F., Quinones, M., Roberts, R. J. Clin. Invest. (1999) [Pubmed]
  11. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death. Marian, A.J., Roberts, R. J. Cardiovasc. Electrophysiol. (1998) [Pubmed]
  12. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury. Marian, A.J., Roberts, R. Ann. Med. (1998) [Pubmed]
  13. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Marian, A.J., Zhao, G., Seta, Y., Roberts, R., Yu, Q.T. Circ. Res. (1997) [Pubmed]
 
WikiGenes - Universities